Advertisement
BHFAN vs CNO
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHFAN is a Hold and CNO is a Buy.
BHFAN in -2.60% downward trend, declining for three consecutive days on October 14, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where BHFAN declined for three days, in 165 of 295 cases, the price declined further within the following month. The odds of a continued downward trend are 56%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BHFAN as a result. In 39 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 44%.
The Moving Average Convergence Divergence Histogram (MACD) for BHFAN turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 17 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 40%.
BHFAN moved below its 50-day moving average on October 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BHFAN crossed bearishly below the 50-day moving average on October 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 6 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 35%.
The Aroon Indicator for BHFAN entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BHFAN's RSI Indicator exited the oversold zone, 28 of 37 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 30 of 53 cases where BHFAN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 57%.
Following a +0.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where BHFAN advanced for three days, in 149 of 300 cases, the price rose further within the following month. The odds of a continued upward trend are 50%.
BHFAN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BHFAN's P/B Ratio (0.000) is slightly lower than the industry average of (1.347). P/E Ratio (0.000) is within average values for comparable stocks, (19.840). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.463). BHFAN has a moderately high Dividend Yield (0.128) as compared to the industry average of (0.046). BHFAN's P/S Ratio (0.000) is slightly lower than the industry average of (1.303).
The Tickeron Price Growth Rating for this company is 70 (best 1 - 100 worst), indicating slightly worse than average price growth. BHFAN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BHFAN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock worse than average.
CNO in upward trend: price rose above 50-day moving average on October 20, 2026
CNO moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend. In 36 of 49 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 73%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 13, 2026. You may want to consider a long position or call options on CNO as a result. In 53 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.
The Moving Average Convergence Divergence (MACD) for CNO just turned positive on October 15, 2026. Looking at past instances where CNO's MACD turned positive, the stock continued to rise in 29 of 47 cases over the following month. The odds of a continued upward trend are 62%.
Following a +1.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where CNO advanced for three days, in 207 of 332 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 10-day moving average for CNO crossed bearishly below the 50-day moving average on September 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 47%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 47%.
CNO broke above its upper Bollinger Band on October 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CNO entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 4 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. CNO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 58 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.978) is normal, around the industry mean (1.347). P/E Ratio (18.720) is within average values for comparable stocks, (19.840). Projected Growth (PEG Ratio) (0.210) is also within normal values, averaging (0.463). Dividend Yield (0.013) settles around the average of (0.046) among similar stocks. P/S Ratio (1.156) is also within normal values, averaging (1.303).
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
BHFAN | CNO | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 82 | 42 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 4 Undervalued | 58 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 4 | |
SMR RATING 1..100 | 100 | 94 | |
PRICE GROWTH RATING 1..100 | 70 | 41 | |
P/E GROWTH RATING 1..100 | 100 | 15 | |
SEASONALITY SCORE 1..100 | n/a | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BHFAN's Valuation (4) in the null industry is somewhat better than the same rating for CNO (58) in the Life Or Health Insurance industry. This means that BHFAN’s stock grew somewhat faster than CNO’s over the last 12 months.
CNO's Profit vs Risk Rating (4) in the Life Or Health Insurance industry is significantly better than the same rating for BHFAN (100) in the null industry. This means that CNO’s stock grew significantly faster than BHFAN’s over the last 12 months.
CNO's SMR Rating (94) in the Life Or Health Insurance industry is in the same range as BHFAN (100) in the null industry. This means that CNO’s stock grew similarly to BHFAN’s over the last 12 months.
CNO's Price Growth Rating (41) in the Life Or Health Insurance industry is in the same range as BHFAN (70) in the null industry. This means that CNO’s stock grew similarly to BHFAN’s over the last 12 months.
CNO's P/E Growth Rating (15) in the Life Or Health Insurance industry is significantly better than the same rating for BHFAN (100) in the null industry. This means that CNO’s stock grew significantly faster than BHFAN’s over the last 12 months.
| BHFAN | CNO | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 76% | N/A |
| Stochastic ODDS (%) | 1 day ago 57% | 1 day ago 59% |
| Momentum ODDS (%) | 1 day ago 44% | 1 day ago 61% |
| MACD ODDS (%) | 1 day ago 40% | 1 day ago 62% |
| TrendWeek ODDS (%) | 1 day ago 58% | 1 day ago 61% |
| TrendMonth ODDS (%) | 1 day ago 50% | 1 day ago 61% |
| Advances ODDS (%) | 14 days ago 50% | 1 day ago 62% |
| Declines ODDS (%) | 9 days ago 56% | 23 days ago 47% |
| BollingerBands ODDS (%) | 1 day ago 68% | 1 day ago 62% |
| Aroon ODDS (%) | 1 day ago 33% | 1 day ago 47% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BHFAN’s FA Score shows that 1 FA rating(s) are green while CNO’s FA Score has 2 green FA rating(s).
- BHFAN’s FA Score: 1 green, 4 red.
- CNO’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BHFAN’s TA Score shows that 4 TA indicator(s) are bullish while CNO’s TA Score has 4 bullish TA indicator(s).
- BHFAN’s TA Score: 4 bullish, 6 bearish.
- CNO’s TA Score: 4 bullish, 5 bearish.
Price Growth
BHFAN (@Life/Health Insurance) experienced а +0.48% price change this week, while CNO (@Life/Health Insurance) price change was +3.47% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +3.61%. For the same industry, the average monthly price growth was -0.30%, and the average quarterly price growth was -1.65%.
Reported Earning Dates
CNO is expected to report earnings on Oct 29, 2026.
Industries' Descriptions
@Life/Health Insurance (+3.61% weekly)Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
Advertisement
BHFAN and
Correlation & Price change
A.I.dvisor indicates that over the last year, BHFAN has been closely correlated with BHFAP. These tickers have moved in lockstep 90% of the time. This A.I.-generated data suggests there is a high statistical probability that if BHFAN jumps, then BHFAP could also see price increases.
| Ticker / NAME | Correlation To BHFAN | 1D Price Change % | ||
|---|---|---|---|---|
| BHFAN | 100% | -0.76% | ||
| BHFAP - BHFAN | 90% Closely correlated | -0.94% | ||
| BHFAO - BHFAN | 88% Closely correlated | -0.39% | ||
| BHFAM - BHFAN | 87% Closely correlated | -1.39% | ||
| BHF - BHFAN | 26% Poorly correlated | -1.30% | ||
| UNM - BHFAN | 20% Poorly correlated | +0.04% | ||
More | ||||
CNO and
Correlation & Price change
A.I.dvisor indicates that over the last year, CNO has been loosely correlated with LNC. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if CNO jumps, then LNC could also see price increases.